Neova Day Therapy
- Manufacturer
- PhotoMedex, Inc
- Effective date
- 2019-06-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 24
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:20:32
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Avobenzone 3% Sunscreen
Homosalate 7% Sunscreen
Octisalate 5% Sunscreen
Octocrylene 6% Sunscreen
OTC - PURPOSE SECTION
Enter section text here
INDICATIONS & USAGE SECTION
- Helps prevent sunburn
- if used as directed with other sun protection measures (seeDirections), decreases the risk of skin cancer and early skin aging caused by the sun.
WARNINGS SECTION
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
INSTRUCTIONS FOR USE SECTION
Directions
- Apply liberally 15 minutes before sun exposure.
- Use a water resistant sunscreen if swimming or sweating
- Reapply at least every 2 hours
- Children under 6 months of age: ask a doctor
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including
- Limit time in the sun, especially from 10 a.m.- 2 p.m.
- Wear long-sleeve shirts, pants, hats and sunglasses.
INACTIVE INGREDIENT SECTION
Inactive Ingredients Ammonium Acrylate/Acrylamide Copolymer, Arachidyl Alcohol, Arachidyl Glucoside, Behenyl Alcohol, Bis (Tripeptide-1) Copper Acetate, Caprylyl Glycol, Cetyl Alcohol, Dimethicone, Glycerin, Glyceryl Stearate, Glycine Soja (Soybean) Seed Extract, Hydrogenated Polydecene, Isododecane, Lecithin, PEG-100 Stearate, Phenoxyethanol, Plankton Extract, Polysorbate 20, Polyisobutene, Prunus Armeniaca (Apricot) Kernel Oil, Sodium Chloride, Sodium Hydroxide, Sorbic Acid, Squalane, Triticum Vulgare (Wheat) Gluten Extract, Water (Aqua), Xanthan Gum. May Contain +/- Ultramarines.
OTHER SAFETY INFORMATION
Other Information Protect this product from excessive heat and direct sun.
OTC - QUESTIONS SECTION
Questions or Comments? Call toll free 1-888-966-1010.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 15 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 15 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 15 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 15 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 15 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 15 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 15 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 15 | |
| APRICOT KERNEL OIL | INACTIVE INGREDIENT | 54JB35T06A | 15 | |
| ARACHIDYL ALCOHOL | INACTIVE INGREDIENT | 1QR1QRA9BU | 15 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 15 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 15 | |
| COPPER PIDOLATE | INACTIVE INGREDIENT | 497G7G1SL1 | 15 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 15 | |
| DOCOSANOL | INACTIVE INGREDIENT | 9G1OE216XY | 15 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 15 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 15 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 15 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 15 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 15 | |
| POLYOXYL 100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 15 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 15 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 15 |
Products#
Every source-derived product name is available through these pages.
- Neova Day Therapy SPF 30
- Homosalate, Octocrylene, Octisalate, Avobenzone
- HOMOSALATE
- OCTOCRYLENE
- OCTISALATE
- AVOBENZONE
- COPPER PIDOLATE
- ISODODECANE
- GLYCERIN
- GLYCERYL MONOSTEARATE
- ARACHIDYL ALCOHOL
- DOCOSANOL
- DIMETHICONE
- CAPRYLYL GLYCOL
- CETYL ALCOHOL
- POLYOXYL 100 STEARATE
- APRICOT KERNEL OIL
- POLYSORBATE 20
- LECITHIN, SOYBEAN
- PHENOXYETHANOL
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62362-184 | 62362-184-01, 62362-184-04, 62362-184-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HOMOSALATE | V06SV4M95S | ACTIB |
| OCTOCRYLENE | 5A68WGF6WM | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| AVOBENZONE | G63QQF2NOX | ACTIB |
| COPPER PIDOLATE | 497G7G1SL1 | IACT |
| ISODODECANE | A8289P68Y2 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| ARACHIDYL ALCOHOL | 1QR1QRA9BU | IACT |
| DOCOSANOL | 9G1OE216XY | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| POLYOXYL 100 STEARATE | YD01N1999R | IACT |
| APRICOT KERNEL OIL | 54JB35T06A | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| LECITHIN, SOYBEAN | 1DI56QDM62 | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| DOCOSANOL | DOCOSANOL | 9G1OE216XY | SOLUTION / TOPICAL | 1.1 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | POWDER, FOR SUSPENSION / ORAL | 1.3 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / TOPICAL | 3.7 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| POLYOXYL 100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8ad2f0c9-e02d-4cc0-bc24-21dcd1328085 | 94f44409-4fc8-44ad-bf93-9e61dd505644 | 2019-06-19 | Warnings | 8ad2f0c9-e02d-4cc0-bc24-21dcd1328085 94f44409-4fc8-44ad-bf93-9e61dd505644 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
